Wellmune WGP® Reduces Allergy Symptoms and
Improves Quality of Life in Ragweed Sufferers
Clinical study results presented at Experimental Biology 2011
WASHINGTON, D.C. — April 14, 2011 — Wellmune WGP® reduces allergy symptoms and improves the quality of life of individuals who suffer from ragweed allergy, according to a new clinical study presented yesterday at Experimental Biology 2011, an annual meeting attracting nearly 13,000 scientists and exhibitors.
Ragweed is a leading cause of seasonal allergy symptoms and affects 36 million Americans. Typical symptoms include nasal congestion, sneezing, itchy eyes and difficulty breathing. The cause is an immune system overreaction to ragweed pollen.
The placebo-controlled, double-blinded study of 48 healthy people subjected to high pollen counts last fall. Individuals consuming Wellmune WGP, a natural immune health ingredient from Biothera, demonstrated statistically significant (p<0.05):
• Reductions in overall allergy symptoms and severity.
• Reductions in key nasal and eye-related allergy symptoms.
• Improvement on the Quality of Life Index, a scientifically validated tool for measuring how participants rate their overall sense of wellness.
“Wellmune provided significant relief to study subjects who suffer from the symptoms of ragweed allergies,” said Shawn Talbott, Ph.D., research director at SupplementWatch and lead investigator on the study. More details are available in the study abstract.
Study Design
A new study equally divided 48 healthy subjects (31 female, 17 male; 39 ± 13 years of age) into two groups. One group consumed a placebo while the other a 250 mg serving of Wellmune WGP daily for four weeks during last September/October in an area of southeast Ohio where local pollen counts were high. Allergy surveys, including the validated Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), were used to assess differences in allergy symptoms.
“Previous research demonstrates that Wellmune WGP can safely prime the immune system to keep the body healthy,” said Don Cox, Ph.D., senior vice president, Biothera Healthcare Research & Development. “This new research shows that Wellmune also has the ability to modulate the immune system when less of a response is needed.”
About Wellmune WGP®
Wellmune WGP is a natural immune health ingredient for foods, beverages and supplements. Derived from a proprietary strain of yeast, peer-reviewed research demonstrates that Wellmune WGP helps mobilize billions of innate immune cells that are part of the body’s natural defenses. Wellmune helps these cells do their jobs effectively without over stimulating the immune system, which can be harmful to long-term health.
Wellmune WGP is patented, Kosher, Halal, non-allergenic and GMO-free. The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health. More information is available at www.wellmune.com.
Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)